hypoactive sexual desire disorder

Study: Fetal head station during OVD does not increase sexual dysfunction/postpartum depressionMidpelvic attempted operative vaginal delivery (aOVD) does not increase risk of sexual dysfunction in women or their male partners nor are the women more likely to manifest symptoms of maternal postpartum depression at 6 months compared to counterparts who had low pelvic aOVD, according to a prospective study.
Flibanserin can cause weight loss in pre/postmenopausal women with HSDD Premenopausal and postmenopausal women treated with the combined agonist/antagonist flibanserin for hypoactive sexual desire disorder (HSDD) are likely to lose weight, according to a post hoc analysis of five studies.
Young People Can Suffer from Sexual DysfunctionAlthough most young people have a healthy sex life, many—and particularly young women— may have one or more sexual dysfunction issues, according to results of health survey.
Impact of Delivery Type on Female Sexual Function ExploredThe route of delivery of a child does not have a long-term effect on female sexual dysfunction in primipara mothers, according to a study.
Brain activation differs in women with HSDD and those with normal sexual functionStudies of hypoactive sexual desire disorder (HSDD) traditionally have focused on behavioral and biologic components of the disease. A new multicenter study, however, sheds light on brain activation patterns during sexual arousal in women with the condition.
Breast cancer survivors report poor sexual healthAn Austrian study highlights the need for ob/gyns to counsel breast cancer survivors about sexual health issues, even years after their treatment for the disease
Uro Pipeline: Bladder Ca drug-device combination begins second phase Ib trialA bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up.
Taking Sides: Should ob/gyns prescribe flibanserin for their patients?
Taking Sides: Should ob/gyns prescribe flibanserin for their patients?A look at the pros and cons of this new drug for women with low sexual desire.
New Products: FDA approves oral agent for HSDD, app helps men with erectile dysfunction and moreIn this round-up of new urology products and services, learn about the FDA approving an oral agent for HSDD, an app that helps men with erectile dysfunction, and more.
Best of AUA 2014: Sexual Function/Dysfunction
Best of AUA 2014: Sexual Function/DysfunctionLandon Trost, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in Orlando, FL, including studies of clostridium collagenase histolyticum (CCH [XIAFLEX]).